Approval status is molecule-specific
Some peptides are FDA-approved for specific indications, while others are investigational, cosmetic, compounded, region-specific, or not approved.
A database category is not a substitute for approved labeling or professional guidance.
Where approval status matters
Start with this section, then use the related links below the guide to move into the database, calculator, tracker, or another guide when that context is useful. Peptidic profile pages include approval status so readers can separate approved labeling from investigational, cosmetic, and research-only contexts.
That distinction is especially important before reading reported effects, vendor language, or dosage context.
Research-only language
Research-only compounds should not be described as proven treatments.
Peptidic uses cautious phrases such as studied for, commonly referenced, reported effects, and educational reference.
Where approval status matters
Use this "Research-only language" section as supporting context rather than as a standalone answer. Peptidic profile pages include approval status so readers can separate approved labeling from investigational, cosmetic, and research-only contexts.
That distinction is especially important before reading reported effects, vendor language, or dosage context.
How Peptidic separates evidence types
Approved labeling, human clinical studies, animal research, in vitro studies, cosmetic ingredient data, and anecdotal claims should not be treated as equal. Each has a different level of reliability and a different relevance to real-world decisions.
When a profile does not have reliable source information in the codebase, Peptidic should avoid pretending that the evidence is stronger than it is. The safer default is a limited-information message and links to source databases where readers can continue research.
Where approval status matters
Use this "How Peptidic separates evidence types" section as supporting context rather than as a standalone answer. Peptidic profile pages include approval status so readers can separate approved labeling from investigational, cosmetic, and research-only contexts.
That distinction is especially important before reading reported effects, vendor language, or dosage context.
Prescription products and approved indications
A prescription peptide product may be approved for a narrow indication, population, formulation, dose form, and label-defined use. That approval should not be generalized to every compound with a similar name or category.
Peptidic presents approval status as a profile field so readers can separate regulated medical products from research-only compounds, cosmetic ingredients, and unsupported marketplace language.
Where approval status matters
Use this "Prescription products and approved indications" section as supporting context rather than as a standalone answer. Peptidic profile pages include approval status so readers can separate approved labeling from investigational, cosmetic, and research-only contexts.
That distinction is especially important before reading reported effects, vendor language, or dosage context.
Research-only and vendor language cautions
Research-only language should be treated as a warning that a product may not be intended for human or animal consumption. It should not be read as a loophole, safety guarantee, or substitute for regulatory review.
Vendor pages sometimes use broad phrases such as high purity, pharmaceutical grade, or lab tested. Those phrases need source documentation, batch-level COAs, and clear labeling before they are useful for research evaluation.
Where approval status matters
Use this "Research-only and vendor language cautions" section as supporting context rather than as a standalone answer. Peptidic profile pages include approval status so readers can separate approved labeling from investigational, cosmetic, and research-only contexts.
That distinction is especially important before reading reported effects, vendor language, or dosage context.